GGrantIndex
← Leaderboards

Jyothi Rengarajan

Emory University

Google Scholar ↗PubMed ↗ORCID ↗
$20,334,619
Attributed
$30,090,405
Total exposure
20
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY2007–25
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$33,993,666 · 21

By mechanism

R01$23,776,865 · 7
U19$4,188,564 · 2
P30$3,903,261 · 1
R00$675,000 · 1
R56$541,546 · 1
R21$507,005 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis”

Research focus

TuberculosisMycobacterium TuberculosisImmuneInsightT-LymphocyteInfectionImmune ResponseResponseMediatingT Cell ResponseLungCellsAntigensVaccinesImmunityMacrophageActivities Of Daily LivingPathogenesisPhenotypeIn VivoTuberculosis ImmunityTuberculosis VaccinesTreatment ProtocolsDesign

Grant awards (66)

Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,120,958
R01 · FY2025 · AI · contact PI
Investigating alveolar macrophages in PLWH as targets for HIV persistence, residual inflammation and immune activation$1,030,790
R01 · FY2025 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$972,283
P30 · FY2025 · AI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$95,603
R01 · FY2025 · AI · contact PI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,130,293
R01 · FY2024 · AI · contact PI
Investigating alveolar macrophages in PLWH as targets for HIV persistence, residual inflammation and immune activation$1,010,290
R01 · FY2024 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$972,283
P30 · FY2024 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy$863,755
R01 · FY2024 · AI · contact PI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy$90,542
R01 · FY2024 · AI · contact PI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$36,083
R01 · FY2024 · AI · contact PI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,192,738
R01 · FY2023 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$972,285
P30 · FY2023 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy$867,492
R01 · FY2023 · AI · contact PI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy$90,542
R01 · FY2023 · AI · contact PI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,255,581
R01 · FY2022 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$986,410
P30 · FY2022 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy$861,166
R01 · FY2022 · AI · contact PI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy$836,957
R01 · FY2021 · AI · contact PI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB$648,004
R01 · FY2021 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$898,189
R01 · FY2020 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB$681,243
R01 · FY2020 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$378,442
U19 · FY2020 · AI · contact PI
Macaque T cell signatures of Mtb control$251,757
U19 · FY2020 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement$148,967
R01 · FY2020 · AI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$899,688
R01 · FY2019 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$890,058
R01 · FY2019 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB$738,657
R01 · FY2019 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$500,373
U19 · FY2019 · AI · contact PI
Macaque T cell signatures of Mtb control$241,509
U19 · FY2019 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$1,034,989
R01 · FY2018 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$822,232
R01 · FY2018 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB$656,929
R01 · FY2018 · AI · contact PI
Macaque T cell signatures of Mtb control$341,845
U19 · FY2018 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$278,082
U19 · FY2018 · AI · contact PI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB$55,093
R01 · FY2018 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$873,043
R01 · FY2017 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$843,809
R01 · FY2017 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB$629,390
R01 · FY2017 · AI · contact PI
Macaque T cell signatures of Mtb control$347,100
U19 · FY2017 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$174,764
U19 · FY2017 · AI · contact PI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$850,330
R01 · FY2016 · AI
Macaque T cell signatures of Mtb control$688,445
U19 · FY2016 · AI · contact PI
Modulation of Host Responses by Mycobacterium tuberculosis$541,546
R56 · FY2016 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$450,176
U19 · FY2016 · AI · contact PI
Targeting an immunomodulatory protease for adjunctive tuberculosis chemotherapy$227,647
R21 · FY2016 · AI · contact PI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$467,190
R01 · FY2015 · AI
Targeting an immunomodulatory protease for adjunctive tuberculosis chemotherapy$279,358
R21 · FY2015 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$271,926
U19 · FY2015 · AI · contact PI
Modulation of Host Responses by Mycobacterium Tuberculosis$435,600
R01 · FY2014 · AI · contact PI
Identification of human Mtb-specific T cell signatures that are associated$264,145
U19 · FY2014 · AI · contact PI
Modulation of Host Responses by Mycobacterium Tuberculosis$409,464
R01 · FY2013 · AI · contact PI
Modulation of Host Responses by Mycobacterium Tuberculosis$435,600
R01 · FY2012 · AI · contact PI
Fourth Southeastern Mycobacteria Meeting$4,000
R13 · FY2012 · AI · contact PI
Modulation of Host Responses by Mycobacterium Tuberculosis$435,600
R01 · FY2011 · AI · contact PI
IMMUNE RESPONSES TO TUBERCULOSIS IN HIV POSITIVE AND HIV NEGATIVE INDIVIDUALS$74,294
P51 · FY2011 · RR · contact PI
MODULATION OF INNATE IMMUNE DEFENSES BY MYCOBACTERIUM TUBERCULOSIS$41,159
P51 · FY2011 · RR · contact PI
CELLULAR IMMUNE RESPONSES TO ACELLULAR PERTUSSIS VACCINATION IN INFANTS$41,159
P51 · FY2011 · RR · contact PI
ROLE OF MYCOBACTERIUM TUBERCULOSIS PROTEASE IN PATHOGENESIS AND HOST RESPONSE$41,159
P51 · FY2011 · RR · contact PI
Modulation of Host Responses by Mycobacterium Tuberculosis$440,000
R01 · FY2010 · AI · contact PI
Role of Mycobacterium tuberculosis protease in pathogenesis and host response$225,000
R00 · FY2010 · TW · contact PI
ROLE OF MYCOBACTERIUM TUBERCULOSIS PROTEASE IN PATHOGENESIS AND HOST RESPONSE$54,827
P51 · FY2010 · RR · contact PI
IMMUNE RESPONSES TO TUBERCULOSIS IN HIV POSITIVE AND HIV NEGATIVE INDIVIDUALS$54,827
P51 · FY2010 · RR · contact PI
Role of Mycobacterium tuberculosis protease in pathogenesis and host response$225,000
R00 · FY2009 · TW · contact PI
Role of Mycobacterium tuberculosis protease in pathogenesis and host response$225,000
R00 · FY2008 · TW · contact PI
Role of Mycobacterium tuberculosis protease in pathogenesis and host response$79,560
K99 · FY2007 · TW · contact PI
Role of Mycobacterium tuberculosis protease in pathogenesis and host response$10,440
K99 · FY2007 · TW · contact PI